Evaluation of suspected malignant hyperthermia events during anesthesia

BMC Anesthesiology

Table 1 Diagnostic findings

No	Age/sex	IVCT	Year of incidence	Surgery	Prev. Anesth.	Genetic status	CGS	Histopathology
1	46 ♂	MHS	2010	Liposuction	1	Negative	48	WPF
2	58 ♂	MHS	2010	Spongiosaplasty	2	Gly4037Alafs	38	WPF
3	36 ♂	MHS	2010	Urachal fistula	-	Negative	43	WPF
4	14 ♂	MHS	2009	Lower leg fracture	-	Glu2174Ala	53	WPF
5	18 ♂	MHS	2008	Gunshot injury	-	Val4234Leu	53	WPF
6	45 ♂	MHS	2007	Hemilaminectomy	-	Negative	38	WPF
7	10 ♂	MHS	1995	Appendectomies	-	Negative	40	WPF
8	62 ♀	MHEh	2009	Bursectomy	-	Negative	15	WPF
9	32 ♀	MHEh	2009	Caesarean section	-	Negative	40	Myopathy
10	29 ♀	MHEh	2006	Uterine abrasion	-	Negative	15	WPF
11	3 ♂	MHEh	1992	Tonsillectomy	-	Negative	18	WPF
12	35 ♀	MHN	2011	Uterine abrasion	2	Negative	18	WPF
13	54 ♂	MHN	2010	Aortocoronary bypass	-	Negative	30	WPF
14	46 ♀	MHN	2009	Uterine abrasion	1	Negative	30	WPF
15	34 ♀	MHN	2008	Colon resection	-	Negative	25	WPF
16	57 ♀	MHN	2007	Inguinal hernia	-	Negative	30	WPF
17	21 ♀	MHN	2007	Mandible fracture	-	Negative	0	WPF
18	39 ♂	MHN	2006	Appendectomies	-	Negative	30	WPF
19	3 ♂	MHN	1998	Orchidopexy	-	Negative	30	WPF

Age Patients’ age MH-suspected episode occurred, IVCT In vitro contracture test, ♂ Male, ♀ Female, MHS Malignant hyperthermia susceptible, MHN Malignant hyperthermia non-susceptible, MHEh Malignant hyperthermia equivocal to halothane, WPF Without pathological finding.

ISSN: 1471-2253